Technologies

HanchorBio’s Novel CD47-SIRPα Therapeutic HCB101 Accepted for Publication in Prestigious Journal of Hematology & Oncology

  • by

​ Prestigious peer-review validates HCB101’s differentiated mechanism and translational strength. Clinical data show a nearly 90% partial response rate in 2L gastric cancer (combo) and safe escalation to 30 mg/kg (mono) TAIPEI, SHANGHAI and SAN… Read More »HanchorBio’s Novel CD47-SIRPα Therapeutic HCB101 Accepted for Publication in Prestigious Journal of Hematology & Oncology

Enclustra Launches Regional HQ in Singapore, Swiss Firm Eyes Talent Growth in High-Tech Manufacturing, R&D

  • by

​ Engineers to oversee tech transfers, support manufacturing partnerships, and co-develop AI-driven solutions with customers SINGAPORE, Oct. 23, 2025 /PRNewswire/ — Switzerland’s Enclustra GmbH today launched Enclustra Asia, its regional headquarters in Singapore, marking a strategic… Read More »Enclustra Launches Regional HQ in Singapore, Swiss Firm Eyes Talent Growth in High-Tech Manufacturing, R&D